Press releases

Month Year

Email alerts

Jun 3, 2013

Medtronic Reaches Major Milestone in Clinical Program for 'IN.PACT Admiral' Drug-Eluting Balloon

Thomson Reuters ONE via COMTEX) --Company Plans to Submit First Module of U.S. Approval Application for Novel Peripheral Angioplasty Device to FDA Over Summer MINNEAPOLIS -- June 3, 2013 --...
May 31, 2013

Endurant AAA Stent Graft Delivers Durable Outcomes for Abdominal Aortic Aneurysm Repair

Thomson Reuters ONE via COMTEX) --Three-Year Clinical Data Presented at Annual Meeting of Society for Vascular Surgery Reaffirms Physician Confidence in Market-Leading Endovascular Device SAN...
May 30, 2013

Medtronic Garners First-Of-Its-Kind FDA Approval for 'AUI' Device with Endurant II AAA Stent Graft System

(Thomson Reuters ONE via COMTEX) --Global Market-Leader in Medical Technology for Endovascular Aortic Repair Also Receives 510(k) Clearance for Sentrant Introducer Sheath MINNEAPOLIS -- May 30,...
May 24, 2013

Medtronic CEO Omar Ishrak to Speak at Sanford Bernstein Strategic Decisions Conference

Thomson Reuters ONE via COMTEX) --MINNEAPOLIS - May 24, 2013 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Sanford...
May 23, 2013

Medtronic's In.Pact Falcon Drug-Eluting Balloon Yields Positive Outcomes in Small Coronary Arteries

Presented at EuroPCR, One-Year Data from BELLO Study Show Durability of Clinical Results Following Treatment of De Novo Lesions with Novel Angioplasty Device

PARIS -- May 23, 2013 -- One-year data from an Italian multicenter randomized controlled trial of the IN.PACT Falcon drug-eluting balloon from Medtronic, Inc. (NYSE: MDT) demonstrate positive and...

Show per page